Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
January 24, 2016
Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes
Karla Mayfield, Dan Siskind, Karl Winckel, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 26, 2026
Low fixed dose rasburicase for tumour lysis syndrome prophylaxis and treatment is feasible and efficacious in the management of haematologic malignancies
Taylor Mackie, Joshua Tobin, Vivien Chan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 15, 2024
Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis
Anna L Di Mauro, Lewis J Austin, Jasmine Zande, et al.
Exploratory Research in Clinical and Social Pharmacy
|
March 16, 2023
Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study
Chariclia Paradissis, Keshia R De Guzman, Michael Barras, et al.
Schizophrenia Bulletin
|
February 6, 2021
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis
Dan Siskind, Erin Gallagher, Karl Winckel, et al.
Therapeutic Advances in Psychopharmacology
|
June 24, 2022
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors
Teodora Andric, Karl Winckel, Timothy David Tanzer, et al.
The Australian and New Zealand Journal of Psychiatry
|
June 24, 2015
Clozapine in the community: Improved access or risky free-for-all?
Karl Winckel, Dan Siskind, Sam Hollingworth, et al.
Expert Opinion on Drug Safety
|
October 1, 2019
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Sam Hollingworth, et al.
Hospital Pharmacy
|
September 2, 2025
Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital
Marissa Ryan, Jane Dunsdon, Karl Winckel, et al.
Diabetes, Obesity & Metabolism
|
December 2, 2017
Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)
Dan J Siskind, Anthony W Russell, Clare Gamble, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Psychopharmacology (Oxford, England)
|
January 24, 2016
Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes
Karla Mayfield, Dan Siskind, Karl Winckel, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 26, 2026
Low fixed dose rasburicase for tumour lysis syndrome prophylaxis and treatment is feasible and efficacious in the management of haematologic malignancies
Taylor Mackie, Joshua Tobin, Vivien Chan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 15, 2024
Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis
Anna L Di Mauro, Lewis J Austin, Jasmine Zande, et al.
Exploratory Research in Clinical and Social Pharmacy
|
March 16, 2023
Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study
Chariclia Paradissis, Keshia R De Guzman, Michael Barras, et al.
Schizophrenia Bulletin
|
February 6, 2021
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis
Dan Siskind, Erin Gallagher, Karl Winckel, et al.
Therapeutic Advances in Psychopharmacology
|
June 24, 2022
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors
Teodora Andric, Karl Winckel, Timothy David Tanzer, et al.
The Australian and New Zealand Journal of Psychiatry
|
June 24, 2015
Clozapine in the community: Improved access or risky free-for-all?
Karl Winckel, Dan Siskind, Sam Hollingworth, et al.
Expert Opinion on Drug Safety
|
October 1, 2019
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Wade Marteene, Karl Winckel, Sam Hollingworth, et al.
Hospital Pharmacy
|
September 2, 2025
Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital
Marissa Ryan, Jane Dunsdon, Karl Winckel, et al.
Diabetes, Obesity & Metabolism
|
December 2, 2017
Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)
Dan J Siskind, Anthony W Russell, Clare Gamble, et al.
Page
of 4